Fiduciary Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.5M | Sell |
83,789
-869
| -1% | -$202K | 1.75% | 13 |
|
|
2025
Q4 | $17.5M | Sell |
84,658
-404
| -0.5% | -$79.9K | 1.47% | 15 |
|
|
2025
Q3 | $15.8M | Sell |
85,062
-750
| -0.9% | -$128K | 1.39% | 16 |
|
|
2025
Q2 | $13.1M | Sell |
85,812
-461
| -0.5% | -$70.9K | 1.23% | 18 |
|
|
2025
Q1 | $14.3M | Sell |
86,273
-138
| -0.2% | -$21.6K | 1.43% | 15 |
|
|
2024
Q4 | $12.5M | Sell |
86,411
-5,479
| -6% | -$849K | 1.25% | 18 |
|
|
2024
Q3 | $14.9M | Sell |
91,890
-663
| -0.7% | -$106K | 1.51% | 13 |
|
|
2024
Q2 | $13.5M | Sell |
92,553
-819
| -0.9% | -$122K | 1.45% | 13 |
|
|
2024
Q1 | $14.8M | Sell |
93,372
-37
| -0% | -$5.89K | 1.61% | 12 |
|
|
2023
Q4 | $14.6M | Sell |
93,409
-884
| -0.9% | -$136K | 1.72% | 12 |
|
|
2023
Q3 | $14.7M | Sell |
94,293
-5,556
| -6% | -$917K | 1.87% | 11 |
|
|
2023
Q2 | $16.5M | Buy |
99,849
+112
| +0.1% | +$18.1K | 2.03% | 10 |
|
|
2023
Q1 | $15.5M | Buy |
99,737
+71
| +0.1% | +$11.5K | 2.01% | 10 |
|
|
2022
Q4 | $17.6M | Sell |
99,666
-1,051
| -1% | -$181K | 2.35% | 7 |
|
|
2022
Q3 | $17.6M | Buy |
100,717
+1,181
| +1% | +$200K | 2.28% | 9 |
|
|
2022
Q2 | $16.6M | Buy |
99,536
+2,523
| +3% | +$450K | 2.08% | 11 |
|
|
2022
Q1 | $17.1M | Buy |
97,013
+260
| +0.3% | +$44.2K | 2.26% | 10 |
|
|
2021
Q4 | $16.6M | Sell |
96,753
-986
| -1% | -$161K | 1.84% | 13 |
|
|
2021
Q3 | $16.2M | Sell |
97,739
-869
| -0.9% | -$148K | 1.84% | 14 |
|
|
2021
Q2 | $17.1M | Buy |
98,608
+694
| +0.7% | +$115K | 1.98% | 11 |
|
|
2021
Q1 | $15.9M | Buy |
97,914
+2,350
| +2% | +$380K | 1.94% | 12 |
|
|
2020
Q4 | $15.9M | Buy |
95,564
+266
| +0.3% | +$39.3K | 2.09% | 10 |
|
|
2020
Q3 | $14.2M | Sell |
95,298
-1,050
| -1% | -$155K | 2.14% | 10 |
|
|
2020
Q2 | $13.5M | Buy |
96,348
+561
| +0.6% | +$81.8K | 2.26% | 9 |
|
|
2020
Q1 | $12.6M | Buy |
95,787
+3,623
| +4% | +$514K | 2.46% | 9 |
|
|
2019
Q4 | $13.4M | Buy |
92,164
+4,791
| +5% | +$650K | 2.14% | 9 |
|
|
2019
Q3 | $11.3M | Buy |
87,373
+2,647
| +3% | +$349K | 1.98% | 12 |
|
|
2019
Q2 | $11.8M | Sell |
84,726
-307
| -0.4% | -$42.5K | 2.12% | 10 |
|
|
2019
Q1 | $11.9M | Buy |
85,033
+1,352
| +2% | +$181K | 2.21% | 9 |
|
|
2018
Q4 | $10.8M | Buy |
83,681
+371
| +0.4% | +$51.8K | 2.23% | 9 |
|
|
2018
Q3 | $11.5M | Buy |
83,310
+3,744
| +5% | +$498K | 2.26% | 8 |
|
|
2018
Q2 | $9.65M | Buy |
79,566
+198
| +0.2% | +$24.7K | 2.04% | 10 |
|
|
2018
Q1 | $10.2M | Sell |
79,368
-170
| -0.2% | -$23K | 2.2% | 9 |
|
|
2017
Q4 | $11.1M | Sell |
79,538
-458
| -0.6% | -$63.8K | 2.37% | 7 |
|
|
2017
Q3 | $10.4M | Buy |
79,996
+1,302
| +2% | +$173K | 2.34% | 8 |
|
|
2017
Q2 | $10.4M | Buy |
78,694
+755
| +1% | +$96.3K | 2.4% | 6 |
|
|
2017
Q1 | $9.71M | Buy |
77,939
+1,264
| +2% | +$151K | 2.3% | 6 |
|
|
2016
Q4 | $8.83M | Sell |
76,675
-133
| -0.2% | -$15.4K | 2.28% | 6 |
|
|
2016
Q3 | $9.07M | Sell |
76,808
-281
| -0.4% | -$34.1K | 2.46% | 6 |
|
|
2016
Q2 | $9.35M | Sell |
77,089
-154
| -0.2% | -$17.5K | 2.6% | 5 |
|
|
2016
Q1 | $8.36M | Buy |
77,243
+1,360
| +2% | +$141K | 2.42% | 6 |
|
|
2015
Q4 | $7.79M | Buy |
75,883
+6,576
| +9% | +$661K | 2.32% | 5 |
|
|
2015
Q3 | $6.47M | Sell |
69,307
-1,691
| -2% | -$164K | 2.15% | 6 |
|
|
2015
Q2 | $6.92M | Buy |
+70,998
| New | +$7.11M | 2.18% | 3 |
|
Other funds holding JNJ
VCM
VPM
Fiduciary Group's JNJ Position: Q1 2026 in Review
Fiduciary Group reduced its Johnson & Johnson (JNJ) stake by 1% in Q1 2026, selling an estimated $202K and leaving 83,789 shares worth $20.5M. The position accounts for 1.75% of the portfolio, ranked #13.
Fiduciary Group first reported a position in JNJ in Q2 2015 and has held it in 44 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Fiduciary Group held 83,789 shares of Johnson & Johnson worth $20.5M as of Q1 2026.
- Fiduciary Group sold 869 Johnson & Johnson shares in Q1 2026, an estimated $202K.
- Johnson & Johnson made up 1.75% of Fiduciary Group's portfolio in Q1 2026, its #13 holding.
- Fiduciary Group first reported a position in Johnson & Johnson in Q2 2015 and has held it in 44 quarters since.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Fiduciary Group's 13F filing for Q1 2026, filed 11 May 2026.